In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin
- PMID: 4790607
- PMCID: PMC444449
- DOI: 10.1128/AAC.3.4.532
In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin
Abstract
Against more than 90% of 200 bacterial strains tested in vitro, the inhibitory concentration of gentamicin and tobramycin was 3.1 mug/ml and that of BB-K 8, a new semisynthetic aminoglycoside derivative of kanamycin, was 6.3 mug/ml.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
